Tag
Saicriti Pharma Private Limited
2 articles
Sai Parenterals Q2 Results, Subsidiary Acquisitions, Management Committee
Sai Parenterals approved Q2 FY27 standalone and consolidated financial results, reporting a consolidated net profit of ₹105.10 million for H1 FY27.
Board approved acquisition of remaining 25% stake in
Sai Parenterals Q2 Net Profit Up 11% YoY
Board approved Q2 FY27 unaudited standalone and consolidated financial results, reporting a net profit of ₹64.86 million.
Acquired remaining 25% stake in subsidiary SP Analytics for ₹25,000, making it